With over 1,100 subjects enrolled across 39 clinical study sites, the company is developing and validating the study.

RVPH READ THE FULL RVPH RESEARCH REPORT Open Label Extension Initial Readout Reviva Pharmaceutical Holdings, Inc.

Cannabidiol is safe and may reduce anxiety levels in patients with advanced breast cancer 2 to 4 hours after ingestion.

The coalition of conservation and environmental groups has filed a challenge to the preliminary permit granted to York Energy Storage.

The guidelines hold coaching centres accountable for false claims regarding course duration, which may mislead students into ...

Bridgeport Public School's aging buildings will need up to $709 million in repairs and other upgrades over the next decade, ...

OTCQB:ZIVO) ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza ...

Ethics approval received in Australia for the initiation of RAD's Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric CancersThe Phase 1 First-In-Human study is designed to assess the safe ...

Santa Rosa County covets a 700-acre Navy field with commercial potential, and is using a $250,000 grant to study what land it ...

Having demonstrated a 71% anytime complete response rate in the preliminary data from the LEGEND study’s pivotal cohort of BCG-unresponsive ...

The WJC’s Technology and Human Rights Institute (TecHRI) unveiled preliminary findings from its Human vs. AI: Comparison of ...